Search

  • Auftragsstatus
  • Eilbestellung
  • Aktionen
ElementsucheElementsucheStruktursucheStruktursuche
(+)-Chinidin, Thermo Scientific Chemicals
(+)-Chinidin, Thermo Scientific Chemicals
(+)-Chinidin, Thermo Scientific Chemicals
Thermo Scientific Chemicals

(+)-Chinidin, Thermo Scientific Chemicals

CAS: 56-54-2 | C20H24N2O2 | 324.42 g/mol
Have Questions?
Ansicht ändernbuttonViewtableView
Menge:
1 g
5 g
25 g
ChemDexTesten Sie die chem dexTM Webanwendung
Katalognummer A12559.03
auch als A12559-03 bezeichnet
Preis (EUR)
26,80
Each
Menge:
1 g
Großbestellung oder individuelle Größe anfordern
Preis (EUR)
26,80
Each
Chemikalien-Kennzeichnungen
CAS56-54-2
IUPAC Name(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol
Molecular FormulaC20H24N2O2
InChI KeyLOUPRKONTZGTKE-LHHVKLHASA-N
SMILESCOC1=CC=C2N=CC=C([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)C2=C1
Mehr anzeigen
SpecificationsSpecification SheetDatenblatt
FormPowder or crystalline powder
Identification (FTIR)Conforms
Optical Rotation+250° to +270° (c=1 in ethanol)
Appearance (Color)White to cream to yellow to brown
Assay (Non-aqueous acid-base Titration)≥94.0 to ≤106.0% (quinidine + dihydroquinidine)
Mehr anzeigen
(+)-Quinidine is used to treat or prevent many types of irregular heartbeats (heart arrhythmias such as atrial fibrillation). It may also be used to treat malaria.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Löslichkeit
Löslich in Methanol, Chloroform, Alkohol (1 g/36 ml), Benzol und DMSO (100 mM). Schwer löslich in Äther und Petrolether. Unlöslich in Wasser.

Hinweise
Lichtempfindlich. Nicht kompatibel mit Oxidationsmitteln.
RUO – Research Use Only

Allgemeine Referenzen:

  1. Dan M.Roden, M.D.; Raymond L.Woosley, M.D., Ph.D.; R.Kirby Primm, M.D. Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. American Heart Journal. 1986, 111, (6)1088-1093
  2. Alain Borgeat, MD; Jean-Jacques Goy, MD; Raymond Maendly, MD; Urs Kaufmann, MD; MilanGrbic, MD; Ueli Sigwart, MD. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. The American Journal of Cardiology. 1986, 58, (6)496-498